Andrew Serafin, CHIEF STRATEGY OFFICER at Harmony Biosciences Holdings, Inc. (HRMY), sold 76,000 shares at $60.71 ($4.6M) on 2022-12-02, disclosed to the SEC on 2022-12-05.
Open-market sale of $4.6M HRMY by CHIEF STRATEGY OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.12 | 37,080 | $2.2M | 48.8% |
| 2 | $60.12 | 37,080 | $2.2M | 48.8% |
| 3 | $60.71 | 920 | $56K | 1.2% |
| 4 | $60.71 | 920 | $56K | 1.2% |
| Total | $60.13 avg | 76,000 | $4.6M | 100% |